{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T03:59:18Z","timestamp":1773287958107,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpurol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pediatric Urology"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.jpurol.2021.10.015","type":"journal-article","created":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T19:23:55Z","timestamp":1635276235000},"page":"14.e1-14.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Clinical significance of tumoral PD-L1 expression in Wilms tumors"],"prefix":"10.1016","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6857-3647","authenticated-orcid":false,"given":"Lijuan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miaomiao","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenxiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiamao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jpurol.2021.10.015_bib1","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/MOP.0b013e32832b323a","article-title":"Wilms' tumor","volume":"21","author":"Davidoff","year":"2009","journal-title":"Curr Opin Pediatr"},{"issue":"2","key":"10.1016\/j.jpurol.2021.10.015_bib2","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/1096-911X(200008)35:2<126::AID-MPO8>3.0.CO;2-4","volume":"35","author":"Jones","year":"2000","journal-title":"Med Pediatr Oncol"},{"issue":"3","key":"10.1016\/j.jpurol.2021.10.015_bib3","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1007\/s12253-019-00601-8","article-title":"Correlations between histological and array comparative genomic hybridization characterizations of wilms tumor","volume":"25","author":"Chiang","year":"2019","journal-title":"Pathol Oncol Res"},{"issue":"1","key":"10.1016\/j.jpurol.2021.10.015_bib4","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cell.2010.03.014","article-title":"Macrophage diversity enhances tumor progression and metastasis","volume":"141","author":"Qian","year":"2010","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.jpurol.2021.10.015_bib5","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.bbrc.2013.04.102","article-title":"The expression of IL-6 and STAT3 might predict progression and unfavorable prognosis in Wilms' tumor","volume":"435","author":"Zhang","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"10.1016\/j.jpurol.2021.10.015_bib6","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/jso.23364","article-title":"Differential expression of STAT1 and IFN-\u03b3 in primary and invasive or metastatic wilms tumors","volume":"108","author":"Liu","year":"2013","journal-title":"J Surg Oncol"},{"issue":"2","key":"10.1016\/j.jpurol.2021.10.015_bib7","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jpurol.2013.09.010","article-title":"Astrocyte elevated gene-1 overexpression in histologically favorable Wilms tumor is related to poor prognosis","volume":"10","author":"Guo","year":"2014","journal-title":"J Pediatr Urol"},{"issue":"5","key":"10.1016\/j.jpurol.2021.10.015_bib8","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.immuni.2016.04.023","article-title":"Targeting T cell Co-receptors for cancer therapy","volume":"44","author":"Callahan","year":"2016","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.jpurol.2021.10.015_bib9","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s41591-019-0382-x","article-title":"Genomic correlates of response to immune checkpoint blockade","volume":"25","author":"Keenan","year":"2019","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.jpurol.2021.10.015_bib10","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1136\/jclinpath-2017-204853","article-title":"PD-L1","volume":"71","author":"Kythreotou","year":"2018","journal-title":"J Clin Pathol"},{"issue":"10","key":"10.1016\/j.jpurol.2021.10.015_bib11","first-page":"3243","article-title":"Prognostic significance of PD-L1 expression and tumor infiltrating lymphocytes in large cell neuroendocrine carcinoma of lung","volume":"10","author":"Ohtaki","year":"2018","journal-title":"Am J Transl Res"},{"issue":"11","key":"10.1016\/j.jpurol.2021.10.015_bib12","doi-asserted-by":"crossref","first-page":"499.e9","DOI":"10.1016\/j.urolonc.2018.07.003","article-title":"Prognostic value of PD-1 and PD-L1 expression in patients with metastatic clear cell renal cell carcinoma","volume":"36","author":"Ueda","year":"2018","journal-title":"Urol Oncol"},{"key":"10.1016\/j.jpurol.2021.10.015_bib13","doi-asserted-by":"crossref","first-page":"104560","DOI":"10.1016\/j.oraloncology.2019.104560","article-title":"Prognostic and clinicopathological significance of PD-L1 and tumor infiltrating lymphocytes in hypopharyngeal squamous cell carcinoma","volume":"102","author":"Hu","year":"2020","journal-title":"Oral Oncol"},{"issue":"4","key":"10.1016\/j.jpurol.2021.10.015_bib14","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/j.juro.2012.11.012","article-title":"B7-h1 as a biomarker for therapy failure in patients with favorable histology Wilms tumor","volume":"189","author":"Routh","year":"2013","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.jpurol.2021.10.015_bib15","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1016\/j.juro.2008.01.056","article-title":"B7-H1 expression in Wilms tumor: correlation with tumor biology and disease recurrence","volume":"179","author":"Routh","year":"2008","journal-title":"J Urol"},{"issue":"6","key":"10.1016\/j.jpurol.2021.10.015_bib16","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1080\/15384047.2019.1583533","article-title":"Predictive and prognostic value of PDL1 protein expression in breast cancer patients in neoadjuvant setting","volume":"20","author":"Wu","year":"2019","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.jpurol.2021.10.015_bib17","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.lungcan.2017.06.006","article-title":"MYC expression correlates with PD-L1 expression in non-small cell lung cancer","volume":"110","author":"Kim","year":"2017","journal-title":"Lung Cancer"},{"issue":"8","key":"10.1016\/j.jpurol.2021.10.015_bib18","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.2217\/fon.13.81","article-title":"Treatment of Wilms tumor in low-income countries: challenges and potential solutions","volume":"9","author":"Israels","year":"2013","journal-title":"Future Oncol"},{"issue":"32","key":"10.1016\/j.jpurol.2021.10.015_bib19","doi-asserted-by":"crossref","first-page":"52889","DOI":"10.18632\/oncotarget.17547","article-title":"PD-L1:a novel prognostic biomarker in head and neck squamous cell carcinoma","volume":"8","author":"M\u00fcller","year":"2017","journal-title":"Oncotarget"},{"issue":"14","key":"10.1016\/j.jpurol.2021.10.015_bib20","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1158\/1078-0432.CCR-15-2665","article-title":"CD44+ cells in head and neck squamous cell carcinoma suppress T-cell-mediated immunity by selective constitutive and inducible expression of PD-L1","volume":"22","author":"Lee","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"11","key":"10.1016\/j.jpurol.2021.10.015_bib21","doi-asserted-by":"crossref","first-page":"5593","DOI":"10.21873\/anticanres.11144","article-title":"Cancer immunology and immunotherapy","volume":"36","author":"Sukari","year":"2016","journal-title":"Anticancer Res"},{"issue":"1","key":"10.1016\/j.jpurol.2021.10.015_bib22","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12885-017-3916-y","article-title":"Heterogeneity of PD-L1 expression in primary tumors and paired lymph node metastases of triple negative breast cancer","volume":"18","author":"Li","year":"2018","journal-title":"BMC Cancer"},{"issue":"7","key":"10.1016\/j.jpurol.2021.10.015_bib23","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1542\/pir.34.7.328","article-title":"Wilms tumor","volume":"34","author":"Friedman","year":"2013","journal-title":"Pediatr Rev"},{"issue":"4","key":"10.1016\/j.jpurol.2021.10.015_bib24","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1158\/1535-7163.MCT-14-0983","article-title":"PD-L1 expression as a predictive biomarker in cancer immunotherapy","volume":"14","author":"Patel","year":"2015","journal-title":"Mol Cancer Therapeut"},{"issue":"4","key":"10.1016\/j.jpurol.2021.10.015_bib25","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1158\/0008-5472.CAN-10-2217","article-title":"B7-H1 overexpression regulates epithelial-mesenchymal transition and accelerates carcinogenesis in skin","volume":"71","author":"Cao","year":"2011","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.jpurol.2021.10.015_bib26","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/annonc\/mdv615","article-title":"Regulation of PD-L1: a novel role of pro-survival signaling in cancer","volume":"27","author":"Chen","year":"2016","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.jpurol.2021.10.015_bib27","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jtho.2018.09.006","article-title":"Correlation of PD-L1 expression with tumor mutation burden and gene signatures for prognosis in early-stage squamous cell lung carcinoma","volume":"14","author":"Yu","year":"2019","journal-title":"J Thorac Oncol"},{"issue":"7","key":"10.1016\/j.jpurol.2021.10.015_bib28","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1159\/000506075","article-title":"Prognostic significance of PD-1, PD-L1 and CD8 gene expression levels in gastric cancer","volume":"98","author":"Ito","year":"2020","journal-title":"Oncology"},{"key":"10.1016\/j.jpurol.2021.10.015_bib29","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.lungcan.2017.08.005","article-title":"PD-L1 expression in advanced NSCLC: insights into risk stratification and treatment selection from a systematic literature review","volume":"112","author":"Brody","year":"2017","journal-title":"Lung Cancer"}],"container-title":["Journal of Pediatric Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477513121004794?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477513121004794?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T13:51:11Z","timestamp":1761486671000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1477513121004794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S1477513121004794"],"URL":"https:\/\/doi.org\/10.1016\/j.jpurol.2021.10.015","relation":{},"ISSN":["1477-5131"],"issn-type":[{"value":"1477-5131","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical significance of tumoral PD-L1 expression in Wilms tumors","name":"articletitle","label":"Article Title"},{"value":"Journal of Pediatric Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpurol.2021.10.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Journal of Pediatric Urology Company. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}